| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 233.66B | 228.93B | 204.13B | 175.63B | 173.70B | 121.28B |
| Gross Profit | 57.74B | 55.92B | 48.99B | 32.76B | 22.04B | 9.99B |
| EBITDA | 30.47B | 30.38B | 25.42B | 13.98B | 8.86B | -8.70B |
| Net Income | 15.46B | 14.56B | 12.41B | 4.24B | 539.00M | -12.16B |
Balance Sheet | ||||||
| Total Assets | 303.62B | 301.47B | 270.92B | 272.31B | 241.72B | 239.03B |
| Cash, Cash Equivalents and Short-Term Investments | 20.63B | 25.68B | 31.81B | 56.03B | 37.94B | 24.59B |
| Total Debt | 160.82B | 149.24B | 138.60B | 153.93B | 136.17B | 130.04B |
| Total Liabilities | 202.51B | 202.10B | 184.31B | 197.72B | 171.13B | 168.24B |
| Stockholders Equity | 101.10B | 99.36B | 86.60B | 74.58B | 70.59B | 70.78B |
Cash Flow | ||||||
| Free Cash Flow | -7.88B | -12.54B | 1.19B | 3.11B | 15.13B | -24.93B |
| Operating Cash Flow | 2.48B | 29.45B | 24.08B | 7.75B | 25.72B | -17.84B |
| Investing Cash Flow | -11.01B | -43.68B | -31.53B | -6.65B | -16.73B | -10.01B |
| Financing Cash Flow | 3.47B | 8.20B | -16.79B | 16.98B | 4.13B | 34.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥28.34B | 2.93 | ― | 1.47% | 16.30% | 137.62% | |
69 Neutral | ¥142.59B | 15.25 | ― | 0.49% | 4.32% | 21.60% | |
63 Neutral | ¥120.90B | 11.12 | ― | 0.30% | 7.60% | 1.74% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥218.43B | 11.13 | ― | 1.58% | 7.87% | -11.21% | |
61 Neutral | ¥9.90B | -20.79 | 32.34% | ― | 18.27% | 1022.42% | |
58 Neutral | ¥13.75B | 2.42 | ― | 0.55% | 24.92% | -17.32% |